mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis
mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis
复制标题
mTOR 依赖性 xCT 上调可阻断黑色素合成并促进肿瘤发生
DOI:
10.1038/s41418-019-0274-0
复制
发表时间:
2019-10-01
影响因子:
12.4
通讯作者:
Zhang, Hongbing
中科院分区:
文献类型:
--
作者:
Li, Chunjia;Chen, Hongyu;Zhang, Hongbing
Loss of either TSC1 or TSC2 causes tuberous sclerosis complex (TSC) via activation of mTOR signaling pathway. The two prominent features of TSC are skin lesions including hypomelanic macules and benign tumors in multiple organs, whose molecular alterations are largely unknown. We report here that Xc−cystine/glutamate antiporter (xCT) was elevated inTsc2−/−orPten−/−cells,Tsc1knockout mouse tissues andTSC2-deficient human kidney tumor. xCT was transcriptionally boosted by mTOR-mediated Oct1 signaling cascade. Augmented xCT led to reduction of eumelanin and elevation of pheomelanin inTsc1skin knockout mice through mTOR signaling pathway. Disruption of xCT suppressed the proliferation and tumorigenesis ofPten-null cells andTsc2-null cells. mTOR hyperactive cells were more sensitive to inhibitors of mTOR or xCT. Combined inhibition of mTOR and xCT synergistically blocked the propagation and oncogenesis of mTOR hyperactive cells. Therefore, oncogenic mTOR activation of xCT is a key connection between aberrant melanin synthesis and tumorigenesis. We suggest that xCT is a novel therapeutic target for TSC and other aberrant mTOR-related diseases.